TEKU

Teku is a biotechnology company developing an automated, end-to-end platform for the manufacturing of cell therapies. Their technology aims to reduce the complexity, cost, and time associated with producing advanced therapies like CAR-T cells. By integrating hardware and software, Teku's platform enables scalable and decentralized manufacturing, addressing one of the primary bottlenecks in the commercialization of cell-based medicines. The company's "operating system" for cell therapy is designed to streamline workflows from process development to clinical production. This approach seeks to make life-saving treatments more accessible by lowering the barriers to high-quality, consistent manufacturing.